How to interpret studies on the impact of legalizing cannabis

Jakob Manthey; Michael J Armstrong; Tobias Hayer; Daniel T Myran; Rosalie Liccardo Pacula; Rosario Queirolo; Jürgen Rehm; Marielle Wirth; Frank Zobel

doi:10.1111/add.16314

How to interpret studies on the impact of legalizing cannabis

Addiction. 2023 Nov;118(11):2242-2243. doi: 10.1111/add.16314. Epub 2023 Aug 6.

Authors

Jakob Manthey^{1

2}, Michael J Armstrong³, Tobias Hayer⁴, Daniel T Myran^{5

6}, Rosalie Liccardo Pacula⁷, Rosario Queirolo⁸, Jürgen Rehm^{9

10

11

12

13

14

15

16}, Marielle Wirth¹⁷, Frank Zobel¹⁸

Affiliations

¹ Centre of Interdisciplinary Addiction Research (ZIS), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
² Department of Psychiatry, Medical Faculty, University of Leipzig, Leipzig, Germany.
³ Department of Finance, Operations and Information Systems, Brock University, St Catharines, Canada.
⁴ Institute of Public Health and Nursing Research, Department for Health and Society, University of Bremen, Bremen, Germany.
⁵ Bruyère Research Institute, Ottawa, Canada.
⁶ Department of Family Medicine, University of Ottawa, Ottawa, Canada.
⁷ Price School of Public Policy and Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, California, Los Angeles, USA.
⁸ Department of Social Sciences, Universidad Católica del Uruguay, Montevideo, Uruguay.
⁹ Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
¹⁰ World Health Organization/Pan American Health Organization Collaborating Centre, Centre for Addiction and Mental Health, Toronto, Canada.
¹¹ Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.
¹² Centre of Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.
¹³ Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
¹⁴ Institute of Medical Science, University of Toronto, Toronto, Canada.
¹⁵ Department of Psychiatry, University of Toronto, Toronto, Canada.
¹⁶ Program on Substance Abuse, Public Health Agency of Catalonia, Program on Substance Abuse and designated WHO CC, Public Health Agency of Catalonia, Barcelona, Spain.
¹⁷ Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, Germany.
¹⁸ Addiction Suisse, Lausanne, Switzerland.

PMID: 37544768
DOI: 10.1111/add.16314

No abstract available

Keywords: Canada; cannabis; causality; commercialization; legalization; policy.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Canada
Cannabis*
Hallucinogens*
Humans
Legislation, Drug
Marijuana Smoking*
Medical Marijuana*

Substances

Medical Marijuana
Hallucinogens